Laboratorio Farmaceutico Erfo Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Laboratorio Farmaceutico Erfo has a total shareholder equity of €7.5M and total debt of €398.0K, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are €10.5M and €3.0M respectively. Laboratorio Farmaceutico Erfo's EBIT is €588.9K making its interest coverage ratio 20. It has cash and short-term investments of €1.5M.
Belangrijke informatie
5.3%
Verhouding schuld/eigen vermogen
€398.02k
Schuld
| Rente dekkingsratio | 20x |
| Contant | €1.52m |
| Aandelen | €7.54m |
| Totaal verplichtingen | €2.98m |
| Totaal activa | €10.52m |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: ERFO's short term assets (€3.7M) exceed its short term liabilities (€2.0M).
Langlopende schulden: ERFO's short term assets (€3.7M) exceed its long term liabilities (€1.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ERFO has more cash than its total debt.
Schuld verminderen: ERFO's debt to equity ratio has increased from 0% to 5.3% over the past 5 years.
Schuldendekking: ERFO's debt is well covered by operating cash flow (329.4%).
Rentedekking: ERFO's interest payments on its debt are well covered by EBIT (20x coverage).